Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Humalog KwikPen 100units/ml inj 3ml pre-filled pens
0601011L0BBAGAF
|
Insulin Humalog | Insulin Lispro | Endocrine System | 51,427 |
|
Humalog 100units/ml solution for injection 3ml cartridges
0601011L0BBACAC
|
Insulin Humalog | Insulin Lispro | Endocrine System | 34,810 |
|
Lyumjev KwikPen 100units/ml inj 3ml pre-filled pens
0601011L0BDADAF
|
Insulin Lyumjev | Insulin Lispro | Endocrine System | 11,804 |
|
Humalog 100units/ml solution for injection 10ml vials
0601011L0BBABAB
|
Insulin Humalog | Insulin Lispro | Endocrine System | 10,596 |
|
Humalog KwikPen 200units/ml inj 3ml pre-filled pens
0601011L0BBAHAG
|
Insulin Humalog | Insulin Lispro | Endocrine System | 10,428 |
|
Lyumjev 100units/ml solution for injection 10ml vials
0601011L0BDABAB
|
Insulin Lyumjev | Insulin Lispro | Endocrine System | 3,090 |
|
Lyumjev 100units/ml solution for injection 3ml cartridges
0601011L0BDACAC
|
Insulin Lyumjev | Insulin Lispro | Endocrine System | 2,558 |
|
Humalog Junior KwikPen 100units/ml inj 3ml pre-filled pens
0601011L0BBAIAF
|
Insulin Humalog | Insulin Lispro | Endocrine System | 2,123 |
|
Lyumjev Junior KwikPen 100units/ml inj 3ml pre-filled pens
0601011L0BDAEAF
|
Insulin Lyumjev | Insulin Lispro | Endocrine System | 1,375 |
|
Insulin lispro 100units/ml inj 3ml cartridges
0601011L0AAACAC
|
Insulin Lispro | Insulin Lispro | Endocrine System | 1,331 |
|
Lyumjev KwikPen 200units/ml inj 3ml pre-filled pens
0601011L0BDAAAG
|
Insulin Lyumjev | Insulin Lispro | Endocrine System | 855 |
|
Insulin lispro 100units/ml solution for injection 10ml vials
0601011L0AAABAB
|
Insulin Lispro | Insulin Lispro | Endocrine System | 725 |
|
Insulin lispro 100units/ml inj 3ml pf dispos dev
0601011L0AAAFAF
|
Insulin Lispro | Insulin Lispro | Endocrine System | 689 |
|
Admelog 100units/ml inj 3ml pre-filled pens
0601011L0BEACAF
|
Insulin Admelog | Insulin Lispro | Endocrine System | 540 |
|
Insulin lispro Sanofi 100units/ml inj 3ml pre-filled pens
0601011L0BCACAF
|
Insulin Lispro (Sanofi) | Insulin Lispro | Endocrine System | 306 |
|
Admelog 100units/ml solution for injection 10ml vials
0601011L0BEABAB
|
Insulin Admelog | Insulin Lispro | Endocrine System | 262 |
|
Admelog 100units/ml solution for injection 3ml cartridges
0601011L0BEAAAC
|
Insulin Admelog | Insulin Lispro | Endocrine System | 102 |
|
Insulin lispro Sanofi 100units/ml inj 3ml cartridges
0601011L0BCABAC
|
Insulin Lispro (Sanofi) | Insulin Lispro | Endocrine System | 78 |
|
Insulin lispro 200units/ml inj 3ml pf dispos dev
0601011L0AAAGAG
|
Insulin Lispro | Insulin Lispro | Endocrine System | 39 |
|
Insulin lispro Sanofi 100units/ml inj 10ml vials
0601011L0BCAAAB
|
Insulin Lispro (Sanofi) | Insulin Lispro | Endocrine System | 29 |
|
Humalog Tempo Pen 100units/ml inj 3ml pre-filled pens
0601011L0BBAJAF
|
Insulin Humalog | Insulin Lispro | Endocrine System | 19 |
|
Humalog Pen 100units/ml inj 3ml pre-filled pens
0601011L0BBAFAF
|
Insulin Humalog | Insulin Lispro | Endocrine System | 10 |
|
Lyumjev Tempo Pen 100units/ml inj 3ml pre-filled pens
0601011L0BDAFAF
|
Insulin Lyumjev | Insulin Lispro | Endocrine System | 9 |
|
Humalog 100units/ml solution for injection 1.5ml cartridges
0601011L0BBAAAA
|
Insulin Humalog | Insulin Lispro | Endocrine System | No data available |
|
Insulin lispro 100units/ml inj 1.5ml cartridges
0601011L0AAAAAA
|
Insulin Lispro | Insulin Lispro | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.